Precision oncology tools may help reduce breast cancer overtreatment
PLOS Medicine editorial highlights how precision oncology tools could safely help breast cancer patients reduce systemic therapies and avoid severe side effects.
FTMQ Health, written by our newsroom0 views
Systemic therapies for breast cancer often focus on achieving remission and survival, but they can cause severe side effects. PLOS Medicine reported on October 26, 2026, that these treatments sometimes offer limited clinical benefit while negatively impacting patient quality of life and physical function. [1]
In an editorial published by PLOS Medicine, author Katarzyna Starowicz discussed how precision oncology tools may help identify individuals who can safely reduce therapy. Using these tools aims to avoid overtreatment without compromising patient outcomes. [1]
Medical options depend on the physical and biological characteristics of the disease, alongside patient age, overall health, and preferences. Treatment categories include local therapy, which is most effective in early stage breast cancer, and systemic treatment, which is generally used in advanced or metastatic disease. [2]
In short
- Systemic breast cancer therapies can cause severe side effects while sometimes offering limited clinical benefit.
- Precision oncology tools may help identify patients who can safely reduce therapy to avoid overtreatment.
- Local therapy is most effective in early stage breast cancer, while systemic treatment is generally used for advanced disease.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Breast cancer treatment: When less is morePLOS Medicine, 11h ago (the report this story comes from)
Background
- [2]Breast cancer treatment on Wikipedia
- [3]Breast on Grokipedia
Our newsroom writes these reports with the help of software, from the 3 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Ohio State trial examines whether probiotics reduce ovarian cancer treatment side effectsMedical Science, 6d ago
- Breast cancer trial in Australia and New Zealand tests chemotherapy avoidanceMedical Science, 5d ago
- Infectious disease expert highlights rising serogroup Y meningococcal infectionsPublic Health, 13d ago
More in Medical Science
- Global antibiotic reduction shows minimal impact on bacterial infection deaths1h ago
- Healthcare research lacks consistent standards for reporting intervention acceptability1h ago
- Missing blood pressure medication reduces cardiovascular protection study shows1d ago
- Teleflex completes patient enrollment for European coronary scaffold study1d ago
- Experts urge structured cardiac screening to prevent sudden deaths in youth3d ago
- Henry Ford Health Begins Trial for Pulmonary Artery Denervation Treatment3d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.
Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.